BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260512
DTEND;VALUE=DATE:20260515
DTSTAMP:20260514T224314
CREATED:20260217T122509Z
LAST-MODIFIED:20260217T122509Z
UID:42924-1778544000-1778803199@www.pharmajournalist.com
SUMMARY:Investigative & Preclinical Toxicology Summit 2026
DESCRIPTION:Optimize Model Selection\, Accelerate Timelines\, Improve Predictivity of Toxicity \nDates: May 12-14 | Location: Boston\, MA \nWhy Attend \nWith nearly 90% of drug candidates failing in the clinic and one-third of those failures driven by safety preclinical toxicology has reached a critical inflection point. Traditional models are no longer sufficient to predict human risk\, leading to costly late-stage attrition and stalled pipelines. \nThe 2026 summit marks a new era for toxicology. Following the FDA’s 2025 roadmap to reduce reliance on animal testing\, adoption of New Approach Methodologies (NAMs)\, including in vitro\, microphysiological\, and computational models\, is accelerating. CROs and technology developers are releasing innovative platforms\, but challenges remain around predictivity\, validation standards\, and regulatory alignment. \nWhat You’ll Learn \nThis industry-led forum is the only meeting dedicated to benchmarking what truly works in predictive toxicology. Key focus areas include: \n\nEvaluating in vivo\, in vitro\, and in silico strategies\nSharing real IND case studies\nDefining fit-for-purpose model selection across modalities\nAdvancing NAM adoption while ensuring regulatory compliance\n\nWho Should Attend \nIf you are responsible for: \n\nDe-risking first-in-human decisions\nImplementing innovative toxicology strategies\nImproving safety translation from preclinical to clinic\n\n…this summit is your essential forum to separate innovation from hype and build strategies that stand up both clinically and regulatorily. \n📥 Download the Event Guide to explore the full agenda\, speakers\, and registration details: \nOrganiser Name: Hanson Wade\nContact: Nisha Poyser-Reid\ninfo@hansonwade.com\n(+1) 617 455 4188
URL:http://www.pharmajournalist.com/event/investigative-preclinical-toxicology-summit-2026/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson  Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR